Literature DB >> 30153885

Hereditary angioedema revisited.

Joseph A Bellanti, Russell A Settipane.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30153885      PMCID： PMC6122288          DOI： 10.2500/aap.2018.39.4169

Source DB:  PubMed          Journal:  Allergy Asthma Proc        ISSN： 1088-5412            Impact factor:   2.587


× No keyword cloud information.
  16 in total

1.  Hereditary angioedema: an instructive model of clinical description, molecular discovery, and development of new effective treatments.

Authors:  Joseph A Bellanti; Russell A Settipane
Journal:  Allergy Asthma Proc       Date:  2011 Sep-Oct       Impact factor: 2.587

2.  Efficacy of recombinant human C1 esterase inhibitor across anatomic locations in acute hereditary angioedema attacks.

Authors:  James W Baker; Jonathan A Bernstein; Joseph R Harper; Anurag Relan; Marc A Riedl
Journal:  Allergy Asthma Proc       Date:  2018-06-28       Impact factor: 2.587

3.  Health-related quality of life with hereditary angioedema following prophylaxis with subcutaneous C1-inhibitor with recombinant hyaluronidase.

Authors:  Karsten Weller; Marcus Maurer; Moshe Fridman; Dylan Supina; Jennifer Schranz; Markus Magerl
Journal:  Allergy Asthma Proc       Date:  2017-01-16       Impact factor: 2.587

Review 4.  Exhaled nitric oxide levels to guide treatment for adults with asthma.

Authors:  Helen L Petsky; Kayleigh M Kew; Cathy Turner; Anne B Chang
Journal:  Cochrane Database Syst Rev       Date:  2016-09-01

5.  Improved diagnostic clarity in shrimp allergic non-dust-mite sensitized patients.

Authors:  Karen Thursday S Tuano; Sara Anvari; Imelda Celine Hanson; Joud Hajjar; Filiz Seeborg; Lenora M Noroski; Danielle Guffey; Grace Kang; Jordan Scott Orange; Carla M Davis
Journal:  Allergy Asthma Proc       Date:  2018-09-01       Impact factor: 2.587

6.  Factors that predict disease severity in atopic dermatitis: The role of serum basal tryptase.

Authors:  Umit Murat Sahiner; Betul Buyuktiryaki; Hatice Eke Gungor; Neriman Sahiner; Abdullah Turasan; Yasemin Altuner Torun; Bulent Enis Sekerel
Journal:  Allergy Asthma Proc       Date:  2018-09-01       Impact factor: 2.587

7.  Meta-analysis of randomized controlled trials for the efficacy and safety of anti-interleukin-13 therapy with lebrikizumab in patients with uncontrolled asthma.

Authors:  Ying Liu; SuZhong Zhang; Ruie Chen; Jieshu Wei; Guanheng Guan; Manru Zhou; Nan Dong; Yingnan Cao
Journal:  Allergy Asthma Proc       Date:  2018-09-01       Impact factor: 2.587

8.  Seasonal variability of exacerbations of severe, uncontrolled eosinophilic asthma and clinical benefits of benralizumab.

Authors:  Lawrence DuBuske; Paul Newbold; Yanping Wu; Frank Trudo
Journal:  Allergy Asthma Proc       Date:  2018-08-04       Impact factor: 2.587

Review 9.  HAE update: determining optimal patient specific therapy.

Authors:  Richard G Gower
Journal:  Allergy Asthma Proc       Date:  2013 Jan-Feb       Impact factor: 2.587

10.  Subcutaneous C1-esterase inhibitor to prevent hereditary angioedema attacks: Safety findings from the COMPACT trial.

Authors:  H Henry Li; Sarah Mycroft; Sandra Christiansen; Daniel N Wood; Henrike Feuersenger; Dipti Pawaskar; Iris Jacobs
Journal:  Allergy Asthma Proc       Date:  2018-08-14       Impact factor: 2.587
View more
  6 in total

1.  Peanuta non grata.

Authors:  Joseph A Bellanti; Russell A Settipane
Journal:  Allergy Asthma Proc       Date:  2019-07-01       Impact factor: 2.587

2.  Genetics, epigenetics, and allergic disease: A gun loaded by genetics and a trigger pulled by epigenetics.

Authors:  Joseph A Bellanti; Russell A Settipane
Journal:  Allergy Asthma Proc       Date:  2019-03-01       Impact factor: 2.587

3.  Innate lymphoid cells: A new family of lymphocytes with involvement from worms to allergic disease.

Authors:  Joseph A Bellanti; Russell A Settipane
Journal:  Allergy Asthma Proc       Date:  2019-05-01       Impact factor: 2.587

4.  Hereditary angioedema again revisited.

Authors:  Joseph A Bellanti; Russell A Settipane
Journal:  Allergy Asthma Proc       Date:  2021-03-01       Impact factor: 2.587

5.  The continuing "1000 faces of asthma".

Authors:  Joseph A Bellanti; Russell A Settipane
Journal:  Allergy Asthma Proc       Date:  2020-05-01       Impact factor: 2.587

6.  Peanuta non grata revisited.

Authors:  Joseph A Bellanti; Russell A Settipane
Journal:  Allergy Asthma Proc       Date:  2019-09-01       Impact factor: 2.587
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.